Abstract
The incidence of lung cancer increases with age. Approximately 50% of non-small cell lung cancer (NSCLC) patients are over 70 years old. Because of the increasing elderly population, treatment approaches in this age group continue to be studied similar to groups of young people. In the current study, 26 patients who underwent radical surgery and adjuvan chemoradiation at Ataturk Chest Diseases and Chest Surgery Training and Research Hospital were evaluated retrospectively. Of 21 patients (81%) were male and the average age was 74.4. Lobectomy was performed in 18 cases, pneumonectomy in 3, sleeve lobectomy in 3 and bilobectomy in 2. There was no perioperative or early period mortality. Overall survival was 24.5 months. From our study, lung cancer surgery and adjuvant therapy can be performed safely with low morbidity in the elderly.
Highlights
Lung cancer is the most lethal cancer type
Because of the increasing elderly population, treatment approaches in this age group continue to be studied similar to groups of young people
More than 50% of non-small cell lung cancer (NSCLC) patients are older than 65 years while over 30% are at least 70 years old at diagnosis but studies in this age group do not contain enough
Summary
The incidence of lung cancer increases worldwide. Lung cancer incidence increases with age and peaks at the age of 60s-70s (Jemal et al, 2010). Different chronological ages and cut-off values are used to identificate the elderly population such as 65, 70 and 75. In the treatment of early stage lung cancer, surgery is the best chance for cure so in appropriate patients surgical treatment should be performed. The incidence of lung cancer increases with age. 50% of non-small cell lung cancer (NSCLC) patients are over 70 years old. Because of the increasing elderly population, treatment approaches in this age group continue to be studied similar to groups of young people. Conclusions: From our study, lung cancer surgery and adjuvant therapy can be performed safely with low morbidity in the elderly
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Asian Pacific journal of cancer prevention : APJCP
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
